MBBS · Pharmacology

Unit 4: Central Nervous System Pharmacology MCQs

65 solved multiple choice questions with answers and short explanations.

Q1. Which mechanism best explains the principal pharmacologic action of Benzodiazepines?

  1. Aenhance GABA-A receptor action by increasing chloride-channel opening frequency
  2. Benhance GABA-A signaling and at higher doses can directly activate the channel
  3. Cpotentiates inhibitory GABA-A neurotransmission
  4. Dserves as a dopamine precursor that crosses the blood-brain barrier
Show answer
Answer: A. enhance GABA-A receptor action by increasing chloride-channel opening frequencyBenzodiazepines enhance GABA-A receptor action by increasing chloride-channel opening frequency. This mechanism accounts for its characteristic pharmacologic effects.
Report a mistake

Q2. Which clinical use is most appropriately associated with Benzodiazepines?

  1. Areversal of selected benzodiazepine sedation
  2. Bacute anxiety, status epilepticus, and procedural sedation
  3. Cdissociative anesthesia and analgesia
  4. Dadjunctive treatment of Parkinson disease
Show answer
Answer: B. acute anxiety, status epilepticus, and procedural sedationBenzodiazepines is used for acute anxiety, status epilepticus, and procedural sedation. Selection still depends on the patient's diagnosis, contraindications, and treatment context.
Report a mistake

Q3. Which adverse effect or toxicity is particularly important to recognize with Benzodiazepines?

  1. Aemergence reactions and increased blood pressure
  2. Brespiratory depression and marked CNS depression
  3. Csedation, impaired coordination, and dependence
  4. Ddoes not itself treat CNS dopamine deficiency when used alone
Show answer
Answer: C. sedation, impaired coordination, and dependenceAn important safety issue with Benzodiazepines is sedation, impaired coordination, and dependence. Recognizing characteristic toxicity is central to safe pharmacotherapy.
Report a mistake

Q4. A drug enhance GABA-A receptor action by increasing chloride-channel opening frequency and is used for acute anxiety, status epilepticus, and procedural sedation. Which drug best matches this description?

  1. AHaloperidol
  2. BBarbiturates
  3. CLevodopa
  4. DBenzodiazepines
Show answer
Answer: D. BenzodiazepinesThe description matches Benzodiazepines: it enhance GABA-A receptor action by increasing chloride-channel opening frequency and is used for acute anxiety, status epilepticus, and procedural sedation.
Report a mistake

Q5. Which mechanism best explains the principal pharmacologic action of Barbiturates?

  1. Aenhance GABA-A signaling and at higher doses can directly activate the channel
  2. Bcompetitively antagonizes the benzodiazepine binding site on GABA-A receptors
  3. Cnoncompetitively antagonizes NMDA glutamate receptors
  4. Dinhibits peripheral aromatic L-amino-acid decarboxylase
Show answer
Answer: A. enhance GABA-A signaling and at higher doses can directly activate the channelBarbiturates enhance GABA-A signaling and at higher doses can directly activate the channel. This mechanism accounts for its characteristic pharmacologic effects.
Report a mistake

Q6. Which clinical use is most appropriately associated with Barbiturates?

  1. Ainduction and maintenance of intravenous anesthesia
  2. Bselected seizure disorders and induction of anesthesia
  3. Csymptomatic treatment of Parkinson disease
  4. Dacute psychosis and severe agitation
Show answer
Answer: B. selected seizure disorders and induction of anesthesiaBarbiturates is used for selected seizure disorders and induction of anesthesia. Selection still depends on the patient's diagnosis, contraindications, and treatment context.
Report a mistake

Q7. Which adverse effect or toxicity is particularly important to recognize with Barbiturates?

  1. Adyskinesias and motor fluctuations
  2. Bseizures in susceptible or dependent patients
  3. Crespiratory depression and marked CNS depression
  4. Dinsomnia and drug interactions at higher exposure
Show answer
Answer: C. respiratory depression and marked CNS depressionAn important safety issue with Barbiturates is respiratory depression and marked CNS depression. Recognizing characteristic toxicity is central to safe pharmacotherapy.
Report a mistake

Q8. A drug enhance GABA-A signaling and at higher doses can directly activate the channel and is used for selected seizure disorders and induction of anesthesia. Which drug best matches this description?

  1. AClozapine
  2. BFlumazenil
  3. CCarbidopa
  4. DBarbiturates
Show answer
Answer: D. BarbituratesThe description matches Barbiturates: it enhance GABA-A signaling and at higher doses can directly activate the channel and is used for selected seizure disorders and induction of anesthesia.
Report a mistake

Q9. Which mechanism best explains the principal pharmacologic action of Flumazenil?

  1. Acompetitively antagonizes the benzodiazepine binding site on GABA-A receptors
  2. Bpotentiates inhibitory GABA-A neurotransmission
  3. Cserves as a dopamine precursor that crosses the blood-brain barrier
  4. Dselectively inhibits MAO-B at usual doses
Show answer
Answer: A. competitively antagonizes the benzodiazepine binding site on GABA-A receptorsFlumazenil competitively antagonizes the benzodiazepine binding site on GABA-A receptors. This mechanism accounts for its characteristic pharmacologic effects.
Report a mistake

Q10. Which clinical use is most appropriately associated with Flumazenil?

  1. Adissociative anesthesia and analgesia
  2. Breversal of selected benzodiazepine sedation
  3. Creducing peripheral levodopa conversion in Parkinson therapy
  4. Dtreatment-resistant schizophrenia
Show answer
Answer: B. reversal of selected benzodiazepine sedationFlumazenil is used for reversal of selected benzodiazepine sedation. Selection still depends on the patient's diagnosis, contraindications, and treatment context.
Report a mistake

Q11. Which adverse effect or toxicity is particularly important to recognize with Flumazenil?

  1. Adoes not itself treat CNS dopamine deficiency when used alone
  2. Bhypotension and respiratory depression
  3. Cseizures in susceptible or dependent patients
  4. Dextrapyramidal symptoms and hyperprolactinemia
Show answer
Answer: C. seizures in susceptible or dependent patientsAn important safety issue with Flumazenil is seizures in susceptible or dependent patients. Recognizing characteristic toxicity is central to safe pharmacotherapy.
Report a mistake

Q12. A drug competitively antagonizes the benzodiazepine binding site on GABA-A receptors and is used for reversal of selected benzodiazepine sedation. Which drug best matches this description?

  1. AFluoxetine
  2. BPropofol
  3. CSelegiline
  4. DFlumazenil
Show answer
Answer: D. FlumazenilThe description matches Flumazenil: it competitively antagonizes the benzodiazepine binding site on GABA-A receptors and is used for reversal of selected benzodiazepine sedation.
Report a mistake

Q13. Which mechanism best explains the principal pharmacologic action of Propofol?

  1. Apotentiates inhibitory GABA-A neurotransmission
  2. Bnoncompetitively antagonizes NMDA glutamate receptors
  3. Cinhibits peripheral aromatic L-amino-acid decarboxylase
  4. Dblocks dopamine D2 receptors
Show answer
Answer: A. potentiates inhibitory GABA-A neurotransmissionPropofol potentiates inhibitory GABA-A neurotransmission. This mechanism accounts for its characteristic pharmacologic effects.
Report a mistake

Q14. Which clinical use is most appropriately associated with Propofol?

  1. Asymptomatic treatment of Parkinson disease
  2. Binduction and maintenance of intravenous anesthesia
  3. Cadjunctive treatment of Parkinson disease
  4. Dmajor depressive disorder and several anxiety-related disorders
Show answer
Answer: B. induction and maintenance of intravenous anesthesiaPropofol is used for induction and maintenance of intravenous anesthesia. Selection still depends on the patient's diagnosis, contraindications, and treatment context.
Report a mistake

Q15. Which adverse effect or toxicity is particularly important to recognize with Propofol?

  1. Ainsomnia and drug interactions at higher exposure
  2. Bemergence reactions and increased blood pressure
  3. Chypotension and respiratory depression
  4. Dagranulocytosis, myocarditis, seizures, and metabolic effects
Show answer
Answer: C. hypotension and respiratory depressionAn important safety issue with Propofol is hypotension and respiratory depression. Recognizing characteristic toxicity is central to safe pharmacotherapy.
Report a mistake

Q16. A drug potentiates inhibitory GABA-A neurotransmission and is used for induction and maintenance of intravenous anesthesia. Which drug best matches this description?

  1. AVenlafaxine
  2. BKetamine
  3. CHaloperidol
  4. DPropofol
Show answer
Answer: D. PropofolThe description matches Propofol: it potentiates inhibitory GABA-A neurotransmission and is used for induction and maintenance of intravenous anesthesia.
Report a mistake

Q17. Which mechanism best explains the principal pharmacologic action of Ketamine?

  1. Anoncompetitively antagonizes NMDA glutamate receptors
  2. Bserves as a dopamine precursor that crosses the blood-brain barrier
  3. Cselectively inhibits MAO-B at usual doses
  4. Dantagonizes multiple receptors including dopamine D2 and serotonin 5-HT2A receptors
Show answer
Answer: A. noncompetitively antagonizes NMDA glutamate receptorsKetamine noncompetitively antagonizes NMDA glutamate receptors. This mechanism accounts for its characteristic pharmacologic effects.
Report a mistake

Q18. Which clinical use is most appropriately associated with Ketamine?

  1. Areducing peripheral levodopa conversion in Parkinson therapy
  2. Bdissociative anesthesia and analgesia
  3. Cacute psychosis and severe agitation
  4. Dmajor depression and anxiety disorders
Show answer
Answer: B. dissociative anesthesia and analgesiaKetamine is used for dissociative anesthesia and analgesia. Selection still depends on the patient's diagnosis, contraindications, and treatment context.
Report a mistake

Q19. Which adverse effect or toxicity is particularly important to recognize with Ketamine?

  1. Aextrapyramidal symptoms and hyperprolactinemia
  2. Bdyskinesias and motor fluctuations
  3. Cemergence reactions and increased blood pressure
  4. Dsexual dysfunction, GI upset, and serotonin toxicity
Show answer
Answer: C. emergence reactions and increased blood pressureAn important safety issue with Ketamine is emergence reactions and increased blood pressure. Recognizing characteristic toxicity is central to safe pharmacotherapy.
Report a mistake

Q20. A drug noncompetitively antagonizes NMDA glutamate receptors and is used for dissociative anesthesia and analgesia. Which drug best matches this description?

  1. AAmitriptyline
  2. BLevodopa
  3. CClozapine
  4. DKetamine
Show answer
Answer: D. KetamineThe description matches Ketamine: it noncompetitively antagonizes NMDA glutamate receptors and is used for dissociative anesthesia and analgesia.
Report a mistake

Q21. Which mechanism best explains the principal pharmacologic action of Levodopa?

  1. Aserves as a dopamine precursor that crosses the blood-brain barrier
  2. Binhibits peripheral aromatic L-amino-acid decarboxylase
  3. Cblocks dopamine D2 receptors
  4. Dselectively inhibits serotonin reuptake
Show answer
Answer: A. serves as a dopamine precursor that crosses the blood-brain barrierLevodopa serves as a dopamine precursor that crosses the blood-brain barrier. This mechanism accounts for its characteristic pharmacologic effects.
Report a mistake

Q22. Which clinical use is most appropriately associated with Levodopa?

  1. Aadjunctive treatment of Parkinson disease
  2. Bsymptomatic treatment of Parkinson disease
  3. Ctreatment-resistant schizophrenia
  4. Ddepression and selected neuropathic pain syndromes
Show answer
Answer: B. symptomatic treatment of Parkinson diseaseLevodopa is used for symptomatic treatment of Parkinson disease. Selection still depends on the patient's diagnosis, contraindications, and treatment context.
Report a mistake

Q23. Which adverse effect or toxicity is particularly important to recognize with Levodopa?

  1. Aagranulocytosis, myocarditis, seizures, and metabolic effects
  2. Bdoes not itself treat CNS dopamine deficiency when used alone
  3. Cdyskinesias and motor fluctuations
  4. Ddose-related hypertension and discontinuation symptoms
Show answer
Answer: C. dyskinesias and motor fluctuationsAn important safety issue with Levodopa is dyskinesias and motor fluctuations. Recognizing characteristic toxicity is central to safe pharmacotherapy.
Report a mistake

Q24. A drug serves as a dopamine precursor that crosses the blood-brain barrier and is used for symptomatic treatment of Parkinson disease. Which drug best matches this description?

  1. ALithium
  2. BCarbidopa
  3. CFluoxetine
  4. DLevodopa
Show answer
Answer: D. LevodopaThe description matches Levodopa: it serves as a dopamine precursor that crosses the blood-brain barrier and is used for symptomatic treatment of Parkinson disease.
Report a mistake

Q25. Which mechanism best explains the principal pharmacologic action of Carbidopa?

  1. Ainhibits peripheral aromatic L-amino-acid decarboxylase
  2. Bselectively inhibits MAO-B at usual doses
  3. Cantagonizes multiple receptors including dopamine D2 and serotonin 5-HT2A receptors
  4. Dinhibits serotonin and norepinephrine reuptake
Show answer
Answer: A. inhibits peripheral aromatic L-amino-acid decarboxylaseCarbidopa inhibits peripheral aromatic L-amino-acid decarboxylase. This mechanism accounts for its characteristic pharmacologic effects.
Report a mistake

Q26. Which clinical use is most appropriately associated with Carbidopa?

  1. Aacute psychosis and severe agitation
  2. Breducing peripheral levodopa conversion in Parkinson therapy
  3. Cmajor depressive disorder and several anxiety-related disorders
  4. Dbipolar disorder
Show answer
Answer: B. reducing peripheral levodopa conversion in Parkinson therapyCarbidopa is used for reducing peripheral levodopa conversion in Parkinson therapy. Selection still depends on the patient's diagnosis, contraindications, and treatment context.
Report a mistake

Q27. Which adverse effect or toxicity is particularly important to recognize with Carbidopa?

  1. Asexual dysfunction, GI upset, and serotonin toxicity
  2. Binsomnia and drug interactions at higher exposure
  3. Cdoes not itself treat CNS dopamine deficiency when used alone
  4. Danticholinergic effects, sedation, and cardiotoxicity in overdose
Show answer
Answer: C. does not itself treat CNS dopamine deficiency when used aloneAn important safety issue with Carbidopa is does not itself treat CNS dopamine deficiency when used alone. Recognizing characteristic toxicity is central to safe pharmacotherapy.
Report a mistake

Q28. A drug inhibits peripheral aromatic L-amino-acid decarboxylase and is used for reducing peripheral levodopa conversion in Parkinson therapy. Which drug best matches this description?

  1. AValproate
  2. BSelegiline
  3. CVenlafaxine
  4. DCarbidopa
Show answer
Answer: D. CarbidopaThe description matches Carbidopa: it inhibits peripheral aromatic L-amino-acid decarboxylase and is used for reducing peripheral levodopa conversion in Parkinson therapy.
Report a mistake

Q29. Which mechanism best explains the principal pharmacologic action of Selegiline?

  1. Aselectively inhibits MAO-B at usual doses
  2. Bblocks dopamine D2 receptors
  3. Cselectively inhibits serotonin reuptake
  4. Dinhibits norepinephrine and serotonin reuptake and also blocks muscarinic, histamine, and alpha receptors
Show answer
Answer: A. selectively inhibits MAO-B at usual dosesSelegiline selectively inhibits MAO-B at usual doses. This mechanism accounts for its characteristic pharmacologic effects.
Report a mistake

Q30. Which clinical use is most appropriately associated with Selegiline?

  1. Atreatment-resistant schizophrenia
  2. Badjunctive treatment of Parkinson disease
  3. Cmajor depression and anxiety disorders
  4. Dgeneralized and focal seizure disorders and bipolar disorder
Show answer
Answer: B. adjunctive treatment of Parkinson diseaseSelegiline is used for adjunctive treatment of Parkinson disease. Selection still depends on the patient's diagnosis, contraindications, and treatment context.
Report a mistake

Q31. Which adverse effect or toxicity is particularly important to recognize with Selegiline?

  1. Adose-related hypertension and discontinuation symptoms
  2. Bextrapyramidal symptoms and hyperprolactinemia
  3. Cinsomnia and drug interactions at higher exposure
  4. Dtremor, hypothyroidism, nephrogenic diabetes insipidus, and teratogenic risk
Show answer
Answer: C. insomnia and drug interactions at higher exposureAn important safety issue with Selegiline is insomnia and drug interactions at higher exposure. Recognizing characteristic toxicity is central to safe pharmacotherapy.
Report a mistake

Q32. A drug selectively inhibits MAO-B at usual doses and is used for adjunctive treatment of Parkinson disease. Which drug best matches this description?

  1. ACarbamazepine
  2. BHaloperidol
  3. CAmitriptyline
  4. DSelegiline
Show answer
Answer: D. SelegilineThe description matches Selegiline: it selectively inhibits MAO-B at usual doses and is used for adjunctive treatment of Parkinson disease.
Report a mistake

Q33. Which mechanism best explains the principal pharmacologic action of Haloperidol?

  1. Ablocks dopamine D2 receptors
  2. Bantagonizes multiple receptors including dopamine D2 and serotonin 5-HT2A receptors
  3. Cinhibits serotonin and norepinephrine reuptake
  4. Dmodulates intracellular second-messenger signaling including inositol pathways
Show answer
Answer: A. blocks dopamine D2 receptorsHaloperidol blocks dopamine D2 receptors. This mechanism accounts for its characteristic pharmacologic effects.
Report a mistake

Q34. Which clinical use is most appropriately associated with Haloperidol?

  1. Amajor depressive disorder and several anxiety-related disorders
  2. Bacute psychosis and severe agitation
  3. Cdepression and selected neuropathic pain syndromes
  4. Dfocal seizures and trigeminal neuralgia
Show answer
Answer: B. acute psychosis and severe agitationHaloperidol is used for acute psychosis and severe agitation. Selection still depends on the patient's diagnosis, contraindications, and treatment context.
Report a mistake

Q35. Which adverse effect or toxicity is particularly important to recognize with Haloperidol?

  1. Aanticholinergic effects, sedation, and cardiotoxicity in overdose
  2. Bagranulocytosis, myocarditis, seizures, and metabolic effects
  3. Cextrapyramidal symptoms and hyperprolactinemia
  4. Dhepatotoxicity, pancreatitis, weight gain, and teratogenicity
Show answer
Answer: C. extrapyramidal symptoms and hyperprolactinemiaAn important safety issue with Haloperidol is extrapyramidal symptoms and hyperprolactinemia. Recognizing characteristic toxicity is central to safe pharmacotherapy.
Report a mistake

Q36. A drug blocks dopamine D2 receptors and is used for acute psychosis and severe agitation. Which drug best matches this description?

  1. ALamotrigine
  2. BClozapine
  3. CLithium
  4. DHaloperidol
Show answer
Answer: D. HaloperidolThe description matches Haloperidol: it blocks dopamine D2 receptors and is used for acute psychosis and severe agitation.
Report a mistake

Q37. Which mechanism best explains the principal pharmacologic action of Clozapine?

  1. Aantagonizes multiple receptors including dopamine D2 and serotonin 5-HT2A receptors
  2. Bselectively inhibits serotonin reuptake
  3. Cinhibits norepinephrine and serotonin reuptake and also blocks muscarinic, histamine, and alpha receptors
  4. Dincreases GABA availability and affects voltage-gated ion channels
Show answer
Answer: A. antagonizes multiple receptors including dopamine D2 and serotonin 5-HT2A receptorsClozapine antagonizes multiple receptors including dopamine D2 and serotonin 5-HT2A receptors. This mechanism accounts for its characteristic pharmacologic effects.
Report a mistake

Q38. Which clinical use is most appropriately associated with Clozapine?

  1. Amajor depression and anxiety disorders
  2. Btreatment-resistant schizophrenia
  3. Cbipolar disorder
  4. Dfocal and generalized seizures and bipolar depression
Show answer
Answer: B. treatment-resistant schizophreniaClozapine is used for treatment-resistant schizophrenia. Selection still depends on the patient's diagnosis, contraindications, and treatment context.
Report a mistake

Q39. Which adverse effect or toxicity is particularly important to recognize with Clozapine?

  1. Atremor, hypothyroidism, nephrogenic diabetes insipidus, and teratogenic risk
  2. Bsexual dysfunction, GI upset, and serotonin toxicity
  3. Cagranulocytosis, myocarditis, seizures, and metabolic effects
  4. Dhyponatremia, blood dyscrasias, and serious skin reactions
Show answer
Answer: C. agranulocytosis, myocarditis, seizures, and metabolic effectsAn important safety issue with Clozapine is agranulocytosis, myocarditis, seizures, and metabolic effects. Recognizing characteristic toxicity is central to safe pharmacotherapy.
Report a mistake

Q40. A drug antagonizes multiple receptors including dopamine D2 and serotonin 5-HT2A receptors and is used for treatment-resistant schizophrenia. Which drug best matches this description?

  1. AEthosuximide
  2. BFluoxetine
  3. CValproate
  4. DClozapine
Show answer
Answer: D. ClozapineThe description matches Clozapine: it antagonizes multiple receptors including dopamine D2 and serotonin 5-HT2A receptors and is used for treatment-resistant schizophrenia.
Report a mistake

Q41. Which mechanism best explains the principal pharmacologic action of Fluoxetine?

  1. Aselectively inhibits serotonin reuptake
  2. Binhibits serotonin and norepinephrine reuptake
  3. Cmodulates intracellular second-messenger signaling including inositol pathways
  4. Duse-dependently blocks voltage-gated sodium channels
Show answer
Answer: A. selectively inhibits serotonin reuptakeFluoxetine selectively inhibits serotonin reuptake. This mechanism accounts for its characteristic pharmacologic effects.
Report a mistake

Q42. Which clinical use is most appropriately associated with Fluoxetine?

  1. Adepression and selected neuropathic pain syndromes
  2. Bmajor depressive disorder and several anxiety-related disorders
  3. Cgeneralized and focal seizure disorders and bipolar disorder
  4. Dabsence seizures
Show answer
Answer: B. major depressive disorder and several anxiety-related disordersFluoxetine is used for major depressive disorder and several anxiety-related disorders. Selection still depends on the patient's diagnosis, contraindications, and treatment context.
Report a mistake

Q43. Which adverse effect or toxicity is particularly important to recognize with Fluoxetine?

  1. Ahepatotoxicity, pancreatitis, weight gain, and teratogenicity
  2. Bdose-related hypertension and discontinuation symptoms
  3. Csexual dysfunction, GI upset, and serotonin toxicity
  4. Dserious rash including Stevens-Johnson syndrome
Show answer
Answer: C. sexual dysfunction, GI upset, and serotonin toxicityAn important safety issue with Fluoxetine is sexual dysfunction, GI upset, and serotonin toxicity. Recognizing characteristic toxicity is central to safe pharmacotherapy.
Report a mistake

Q44. A drug selectively inhibits serotonin reuptake and is used for major depressive disorder and several anxiety-related disorders. Which drug best matches this description?

  1. APhenytoin
  2. BVenlafaxine
  3. CCarbamazepine
  4. DFluoxetine
Show answer
Answer: D. FluoxetineThe description matches Fluoxetine: it selectively inhibits serotonin reuptake and is used for major depressive disorder and several anxiety-related disorders.
Report a mistake

Q45. Which mechanism best explains the principal pharmacologic action of Venlafaxine?

  1. Ainhibits serotonin and norepinephrine reuptake
  2. Binhibits norepinephrine and serotonin reuptake and also blocks muscarinic, histamine, and alpha receptors
  3. Cincreases GABA availability and affects voltage-gated ion channels
  4. Dblocks voltage-gated sodium channels and reduces glutamate release
Show answer
Answer: A. inhibits serotonin and norepinephrine reuptakeVenlafaxine inhibits serotonin and norepinephrine reuptake. This mechanism accounts for its characteristic pharmacologic effects.
Report a mistake

Q46. Which clinical use is most appropriately associated with Venlafaxine?

  1. Abipolar disorder
  2. Bmajor depression and anxiety disorders
  3. Cfocal seizures and trigeminal neuralgia
  4. Dfocal and generalized tonic-clonic seizures
Show answer
Answer: B. major depression and anxiety disordersVenlafaxine is used for major depression and anxiety disorders. Selection still depends on the patient's diagnosis, contraindications, and treatment context.
Report a mistake

Q47. Which adverse effect or toxicity is particularly important to recognize with Venlafaxine?

  1. Ahyponatremia, blood dyscrasias, and serious skin reactions
  2. Banticholinergic effects, sedation, and cardiotoxicity in overdose
  3. Cdose-related hypertension and discontinuation symptoms
  4. DGI distress, fatigue, and headache
Show answer
Answer: C. dose-related hypertension and discontinuation symptomsAn important safety issue with Venlafaxine is dose-related hypertension and discontinuation symptoms. Recognizing characteristic toxicity is central to safe pharmacotherapy.
Report a mistake

Q48. A drug inhibits serotonin and norepinephrine reuptake and is used for major depression and anxiety disorders. Which drug best matches this description?

  1. AMorphine
  2. BAmitriptyline
  3. CLamotrigine
  4. DVenlafaxine
Show answer
Answer: D. VenlafaxineThe description matches Venlafaxine: it inhibits serotonin and norepinephrine reuptake and is used for major depression and anxiety disorders.
Report a mistake

Q49. Which mechanism best explains the principal pharmacologic action of Amitriptyline?

  1. Ainhibits norepinephrine and serotonin reuptake and also blocks muscarinic, histamine, and alpha receptors
  2. Bmodulates intracellular second-messenger signaling including inositol pathways
  3. Cuse-dependently blocks voltage-gated sodium channels
  4. Dblocks thalamic T-type calcium channels
Show answer
Answer: A. inhibits norepinephrine and serotonin reuptake and also blocks muscarinic, histamine, and alpha receptorsAmitriptyline inhibits norepinephrine and serotonin reuptake and also blocks muscarinic, histamine, and alpha receptors. This mechanism accounts for its characteristic pharmacologic effects.
Report a mistake

Q50. Which clinical use is most appropriately associated with Amitriptyline?

  1. Ageneralized and focal seizure disorders and bipolar disorder
  2. Bdepression and selected neuropathic pain syndromes
  3. Cfocal and generalized seizures and bipolar depression
  4. Dsevere pain
Show answer
Answer: B. depression and selected neuropathic pain syndromesAmitriptyline is used for depression and selected neuropathic pain syndromes. Selection still depends on the patient's diagnosis, contraindications, and treatment context.
Report a mistake

Q51. Which adverse effect or toxicity is particularly important to recognize with Amitriptyline?

  1. Aserious rash including Stevens-Johnson syndrome
  2. Btremor, hypothyroidism, nephrogenic diabetes insipidus, and teratogenic risk
  3. Canticholinergic effects, sedation, and cardiotoxicity in overdose
  4. Dgingival hyperplasia, hirsutism, ataxia, and teratogenicity
Show answer
Answer: C. anticholinergic effects, sedation, and cardiotoxicity in overdoseAn important safety issue with Amitriptyline is anticholinergic effects, sedation, and cardiotoxicity in overdose. Recognizing characteristic toxicity is central to safe pharmacotherapy.
Report a mistake

Q52. A drug inhibits norepinephrine and serotonin reuptake and also blocks muscarinic, histamine, and alpha receptors and is used for depression and selected neuropathic pain syndromes. Which drug best matches this description?

  1. ANaloxone
  2. BLithium
  3. CEthosuximide
  4. DAmitriptyline
Show answer
Answer: D. AmitriptylineThe description matches Amitriptyline: it inhibits norepinephrine and serotonin reuptake and also blocks muscarinic, histamine, and alpha receptors and is used for depression and selected neuropathic pain syndromes.
Report a mistake

Q53. Which mechanism best explains the principal pharmacologic action of Lithium?

  1. Amodulates intracellular second-messenger signaling including inositol pathways
  2. Bincreases GABA availability and affects voltage-gated ion channels
  3. Cblocks voltage-gated sodium channels and reduces glutamate release
  4. Dprolongs inactivated state of voltage-gated sodium channels
Show answer
Answer: A. modulates intracellular second-messenger signaling including inositol pathwaysLithium modulates intracellular second-messenger signaling including inositol pathways. This mechanism accounts for its characteristic pharmacologic effects.
Report a mistake

Q54. Which clinical use is most appropriately associated with Lithium?

  1. Afocal seizures and trigeminal neuralgia
  2. Bbipolar disorder
  3. Cabsence seizures
  4. Demergency reversal of opioid-induced respiratory depression
Show answer
Answer: B. bipolar disorderLithium is used for bipolar disorder. Selection still depends on the patient's diagnosis, contraindications, and treatment context.
Report a mistake

Q55. Which adverse effect or toxicity is particularly important to recognize with Lithium?

  1. AGI distress, fatigue, and headache
  2. Bhepatotoxicity, pancreatitis, weight gain, and teratogenicity
  3. Ctremor, hypothyroidism, nephrogenic diabetes insipidus, and teratogenic risk
  4. Drespiratory depression, constipation, miosis, and dependence
Show answer
Answer: C. tremor, hypothyroidism, nephrogenic diabetes insipidus, and teratogenic riskAn important safety issue with Lithium is tremor, hypothyroidism, nephrogenic diabetes insipidus, and teratogenic risk. Recognizing characteristic toxicity is central to safe pharmacotherapy.
Report a mistake

Q56. A drug modulates intracellular second-messenger signaling including inositol pathways and is used for bipolar disorder. Which drug best matches this description?

  1. ASumatriptan
  2. BValproate
  3. CPhenytoin
  4. DLithium
Show answer
Answer: D. LithiumThe description matches Lithium: it modulates intracellular second-messenger signaling including inositol pathways and is used for bipolar disorder.
Report a mistake

Q57. Which mechanism best explains the principal pharmacologic action of Valproate?

  1. Aincreases GABA availability and affects voltage-gated ion channels
  2. Buse-dependently blocks voltage-gated sodium channels
  3. Cblocks thalamic T-type calcium channels
  4. Dactivates mu-opioid receptors
Show answer
Answer: A. increases GABA availability and affects voltage-gated ion channelsValproate increases GABA availability and affects voltage-gated ion channels. This mechanism accounts for its characteristic pharmacologic effects.
Report a mistake

Q58. Which clinical use is most appropriately associated with Valproate?

  1. Afocal and generalized seizures and bipolar depression
  2. Bgeneralized and focal seizure disorders and bipolar disorder
  3. Cfocal and generalized tonic-clonic seizures
  4. Dacute migraine attacks
Show answer
Answer: B. generalized and focal seizure disorders and bipolar disorderValproate is used for generalized and focal seizure disorders and bipolar disorder. Selection still depends on the patient's diagnosis, contraindications, and treatment context.
Report a mistake

Q59. Which adverse effect or toxicity is particularly important to recognize with Valproate?

  1. Agingival hyperplasia, hirsutism, ataxia, and teratogenicity
  2. Bhyponatremia, blood dyscrasias, and serious skin reactions
  3. Chepatotoxicity, pancreatitis, weight gain, and teratogenicity
  4. Dacute withdrawal in opioid-dependent patients
Show answer
Answer: C. hepatotoxicity, pancreatitis, weight gain, and teratogenicityAn important safety issue with Valproate is hepatotoxicity, pancreatitis, weight gain, and teratogenicity. Recognizing characteristic toxicity is central to safe pharmacotherapy.
Report a mistake

Q60. A drug increases GABA availability and affects voltage-gated ion channels and is used for generalized and focal seizure disorders and bipolar disorder. Which drug best matches this description?

  1. ABenzodiazepines
  2. BCarbamazepine
  3. CMorphine
  4. DValproate
Show answer
Answer: D. ValproateThe description matches Valproate: it increases GABA availability and affects voltage-gated ion channels and is used for generalized and focal seizure disorders and bipolar disorder.
Report a mistake

Q61. Which mechanism best explains the principal pharmacologic action of Carbamazepine?

  1. Ause-dependently blocks voltage-gated sodium channels
  2. Bblocks voltage-gated sodium channels and reduces glutamate release
  3. Cprolongs inactivated state of voltage-gated sodium channels
  4. Dcompetitively antagonizes opioid receptors
Show answer
Answer: A. use-dependently blocks voltage-gated sodium channelsCarbamazepine use-dependently blocks voltage-gated sodium channels. This mechanism accounts for its characteristic pharmacologic effects.
Report a mistake

Q62. Which clinical use is most appropriately associated with Carbamazepine?

  1. Aabsence seizures
  2. Bfocal seizures and trigeminal neuralgia
  3. Csevere pain
  4. Dacute anxiety, status epilepticus, and procedural sedation
Show answer
Answer: B. focal seizures and trigeminal neuralgiaCarbamazepine is used for focal seizures and trigeminal neuralgia. Selection still depends on the patient's diagnosis, contraindications, and treatment context.
Report a mistake

Q63. Which adverse effect or toxicity is particularly important to recognize with Carbamazepine?

  1. Arespiratory depression, constipation, miosis, and dependence
  2. Bserious rash including Stevens-Johnson syndrome
  3. Chyponatremia, blood dyscrasias, and serious skin reactions
  4. Dcoronary vasoconstriction and chest pressure
Show answer
Answer: C. hyponatremia, blood dyscrasias, and serious skin reactionsAn important safety issue with Carbamazepine is hyponatremia, blood dyscrasias, and serious skin reactions. Recognizing characteristic toxicity is central to safe pharmacotherapy.
Report a mistake

Q64. A drug use-dependently blocks voltage-gated sodium channels and is used for focal seizures and trigeminal neuralgia. Which drug best matches this description?

  1. ABarbiturates
  2. BLamotrigine
  3. CNaloxone
  4. DCarbamazepine
Show answer
Answer: D. CarbamazepineThe description matches Carbamazepine: it use-dependently blocks voltage-gated sodium channels and is used for focal seizures and trigeminal neuralgia.
Report a mistake

Q65. Which mechanism best explains the principal pharmacologic action of Lamotrigine?

  1. Ablocks voltage-gated sodium channels and reduces glutamate release
  2. Bblocks thalamic T-type calcium channels
  3. Cactivates mu-opioid receptors
  4. Dagonizes 5-HT1B/1D receptors
Show answer
Answer: A. blocks voltage-gated sodium channels and reduces glutamate releaseLamotrigine blocks voltage-gated sodium channels and reduces glutamate release. This mechanism accounts for its characteristic pharmacologic effects.
Report a mistake